Standard Biotools (LAB) Return on Capital Employed Growth (1y) (2012 - 2026)
Standard Biotools (LAB) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.67 Bn | 194.07 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 119.87 Bn | 110.65 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.80 Bn | 73.27 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.41 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.56 Bn | 32.61 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 216.00 |
| 10 | Standard Biotools | 258.10 Mn | -218.62 Mn | 10.54 Mn | 586.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 586.00 |
| Mar 31, 2026 | 332.00 |
| Dec 31, 2025 | -10.00 |
| Sep 30, 2025 | -125.00 |
| Jun 30, 2025 | -95.00 |
| Mar 31, 2025 | 765.00 |
| Dec 31, 2024 | 988.00 |
| Sep 30, 2024 | 170.00 |
| Jun 30, 2024 | 509.00 |
| Mar 31, 2024 | 320.00 |
| Dec 31, 2023 | -217.00 |
| Sep 30, 2023 | 1,381.00 |
| Jun 30, 2023 | 2,407.00 |
| Mar 31, 2023 | 3,044.00 |
| Sep 30, 2022 | 1,448.00 |
| Jun 30, 2022 | -1,860.00 |
| Mar 31, 2022 | -4,047.00 |
| Sep 30, 2021 | -3,743.00 |
| Jun 30, 2021 | -1,119.00 |
| Mar 31, 2021 | 52.00 |